• WY-14643 (Pirinixic Acid): Advanced PPARα Agonism for Tum...

  2025-10-23

  Discover the unique dual role of WY-14643, a selective PPARα agonist, in metabolic disorder research and tumor microenvironment modulation. This article explores novel mechanistic insights, translational applications, and future research directions, standing apart from existing reviews.

• WY-14643: Selective PPARα Agonist for Metabolic and Tumor...

  2025-10-22

  WY-14643 (Pirinixic Acid) is a selective PPARα agonist that empowers researchers to dissect lipid metabolism and inflammation pathways in both metabolic disorder and tumor microenvironment studies. Its dual PPARα/γ activity, robust anti-inflammatory effects, and proven impact on metabolic endpoints set it apart as a versatile tool for advanced mechanistic research and translational applications.

• T7 RNA Polymerase: Precision In Vitro RNA Synthesis for A...

  2025-10-21

  T7 RNA Polymerase empowers scientists with unparalleled specificity for T7 promoter-driven in vitro transcription, driving breakthroughs in RNA vaccine production and functional RNA studies. This recombinant enzyme’s robust performance from linearized plasmid templates enables high-yield, consistent RNA synthesis, setting a new benchmark for molecular biology workflows. Explore how T7 RNA Polymerase unlocks next-generation research with optimized protocols, troubleshooting strategies, and proven success in mRNA therapeutics.

318 records 22/22 page Previous First page 上5页 2122